Wellness brand Elixinol will sell off non-core assets and aim to unlock “restricted cash” as it […]
ASX Cannabis Quarterly Wrap: Elixinol, Emyria, Ecofibre, LGP, Bioxyne, Epsilon, Melodiol, MGC Pharma, AusCann, Neurotech, Wellnex, InhaleRx, Cannasouth
The Cannabis Observer
·
FOUNDING MEMBERS
First 100 readers lock in 50% off for life
Sector coverage written for operators, not tourists. Reserve founding-member pricing before launch.
- Weekday briefings on regulation, access schemes, and the companies shaping the market
- Full archive and weekly deep-dives once premium goes live
- 50% off the launch price, locked in for as long as your subscription stays active
Join 87 readers already on the waitlist
Bioxyne
Breathe Life Sciences
Dr Michael Winlo
Dr Watson
Ecofibre
Elixinol Wellness
Emyria
Epsilon Healthcare
Eric Wang
George Karafotias
Health House International
InhaleRx
Melodiol Global Health
Mernova Medical
Neurotech International
PANDAS/PANS
Ron Dufficy
The Sustainable Nutrition Group
Wellnex Life
Related Articles
